GRAIL/$GRAL

1D1W1MYTD1Y5YMAX

About GRAIL

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Ticker
$GRAL
Sector
Health
Primary listing
NASDAQ
Employees
910
Headquarters
Menlo Park, United States
Website
grail.com

GRAIL Metrics

BasicAdvanced
$3.1B
-
-$9.75
3.25
-

What the Analysts think about GRAIL

Analyst ratings (Buy, Hold, Sell) for GRAIL stock.

GRAIL Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

GRAIL Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

GRAIL News

AllArticlesVideos

GRAIL Highlights Galleri Growth Ahead of Key FDA Advisory Meeting

MarketBeat4 days ago

FDA Panel Schedules to Evaluate GRAIL Premarket Approval Application for Multi-Cancer Early Detection Test

Benzinga1 week ago

US FDA to hold advisory meeting to review Grail's multi-cancer test

Reuters2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.